175 related articles for article (PubMed ID: 29113666)
41. Prognostic impact of blood biomarkers TS and DPD in neoadjuvant-treated esophageal cancer patients.
Grimminger PP; Maus MK; Bergenthal J; Wandhöfer C; Fetzner UK; Herbold T; Bollschweiler E; Hölscher AH; Brabender J
Anticancer Res; 2015 Mar; 35(3):1297-302. PubMed ID: 25750278
[TBL] [Abstract][Full Text] [Related]
42. Prognostic Value of Expression of MicroRNAs in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
Zhan B; Lu D; Luo P; Wang B
Clin Lab; 2016 Nov; 62(11):2203-2211. PubMed ID: 28164670
[TBL] [Abstract][Full Text] [Related]
43. Prediction of Response to Neoadjuvant Chemotherapy and Radiation Therapy with Baseline and Restaging
Beukinga RJ; Hulshoff JB; Mul VEM; Noordzij W; Kats-Ugurlu G; Slart RHJA; Plukker JTM
Radiology; 2018 Jun; 287(3):983-992. PubMed ID: 29533721
[TBL] [Abstract][Full Text] [Related]
44. Prognostic factors, patterns of recurrence and toxicity for patients with esophageal cancer undergoing definitive radiotherapy or chemo-radiotherapy.
Haefner MF; Lang K; Krug D; Koerber SA; Uhlmann L; Kieser M; Debus J; Sterzing F
J Radiat Res; 2015 Jul; 56(4):742-9. PubMed ID: 25907360
[TBL] [Abstract][Full Text] [Related]
45. Pre-therapeutic molecular biomarkers of pathological response to neoadjuvant chemotherapy in gastric and esophago-gastric junction adenocarcinoma: A systematic review and meta-analysis.
Nurczyk K; Nowak N; Carlson R; Skoczylas T; Wallner G
Adv Med Sci; 2023 Mar; 68(1):138-146. PubMed ID: 36944288
[TBL] [Abstract][Full Text] [Related]
46. Significant prognostic value of circulating tumor cells in esophageal cancer patients: A meta-analysis.
Wang S; Du H; Li G
Oncotarget; 2017 Feb; 8(9):15815-15826. PubMed ID: 28178659
[TBL] [Abstract][Full Text] [Related]
47. Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: systematic review with meta-analysis combining individual patient and aggregate data.
Ronellenfitsch U; Schwarzbach M; Hofheinz R; Kienle P; Kieser M; Slanger TE; Burmeister B; Kelsen D; Niedzwiecki D; Schuhmacher C; Urba S; van de Velde C; Walsh TN; Ychou M; Jensen K
Eur J Cancer; 2013 Oct; 49(15):3149-58. PubMed ID: 23800671
[TBL] [Abstract][Full Text] [Related]
48. Meta-Analysis of Prognostic and Clinical Significance of CD44v6 in Esophageal Cancer.
Hu B; Luo W; Hu RT; Zhou Y; Qin SY; Jiang HX
Medicine (Baltimore); 2015 Aug; 94(31):e1238. PubMed ID: 26252284
[TBL] [Abstract][Full Text] [Related]
49. Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with potentially curable esophageal cancer.
van Heijl M; Omloo JM; van Berge Henegouwen MI; Hoekstra OS; Boellaard R; Bossuyt PM; Busch OR; Tilanus HW; Hulshof MC; van der Gaast A; Nieuwenhuijzen GA; Bonenkamp HJ; Plukker JT; Cuesta MA; Ten Kate FJ; Pruim J; van Dekken H; Bergman JJ; Sloof GW; van Lanschot JJ
Ann Surg; 2011 Jan; 253(1):56-63. PubMed ID: 21233607
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of miR-21 and miR-375 as prognostic biomarkers in esophageal cancer.
Winther M; Alsner J; Tramm T; Baeksgaard L; Holtved E; Nordsmark M
Acta Oncol; 2015; 54(9):1582-91. PubMed ID: 26481465
[TBL] [Abstract][Full Text] [Related]
51. Prognostic value of C-reactive protein in esophageal cancer: a meta-analysis.
Zheng TL; Cao K; Liang C; Zhang K; Guo HZ; Li DP; Zhao S
Asian Pac J Cancer Prev; 2014; 15(19):8075-81. PubMed ID: 25338987
[TBL] [Abstract][Full Text] [Related]
52. Inflammatory cytokines are associated with response and prognosis in patients with esophageal cancer.
Blank S; Nienhüser H; Dreikhausen L; Sisic L; Heger U; Ott K; Schmidt T
Oncotarget; 2017 Jul; 8(29):47518-47532. PubMed ID: 28537901
[TBL] [Abstract][Full Text] [Related]
53. Surrogacy of progression-free survival (PFS) for overall survival (OS) in esophageal cancer trials with preoperative therapy: Literature-based meta-analysis.
Kataoka K; Nakamura K; Mizusawa J; Kato K; Eba J; Katayama H; Shibata T; Fukuda H
Eur J Surg Oncol; 2017 Oct; 43(10):1956-1961. PubMed ID: 28747249
[TBL] [Abstract][Full Text] [Related]
54. Vascular endothelial growth factor-C expression as a biomarker of poor prognosis in esophageal squamous cell carcinoma: a meta-analysis.
Tullavardhana T; Akranurakkul P; Ungkitphaiboon W; Songtish D
Oncol Res Treat; 2015; 38(3):110-4. PubMed ID: 25792082
[TBL] [Abstract][Full Text] [Related]
55. The roles of excision repair cross-complementation group1 in objective response after cisplatin-based concurrent chemoradiotherapy and survival in head and neck cancers: a systematic review and meta-analysis.
Gao Y; Liu D
Oral Oncol; 2015 Jun; 51(6):570-7. PubMed ID: 25857670
[TBL] [Abstract][Full Text] [Related]
56. Roles of thymidylate synthase and dihydropyrimidine dehydrogenase expression in blood as predictors of response to multimodal therapy in esophageal cancer.
Brabender J; Metzger R; Vallböhmer D; Ling F; Neiss S; Bollschweiler E; Schneider PM; Hölscher AH; Grimminger PP
Surgery; 2012 Feb; 151(2):306-12. PubMed ID: 21982526
[TBL] [Abstract][Full Text] [Related]
57. The value of tumor infiltrating lymphocytes (TILs) for predicting response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis.
Mao Y; Qu Q; Zhang Y; Liu J; Chen X; Shen K
PLoS One; 2014; 9(12):e115103. PubMed ID: 25501357
[TBL] [Abstract][Full Text] [Related]
58. Correlation of pathological complete response with survival after neoadjuvant chemotherapy in gastric or gastroesophageal junction cancer treated with radical surgery: A meta-analysis.
Li Z; Shan F; Wang Y; Zhang Y; Zhang L; Li S; Jia Y; Xue K; Miao R; Li Z; Ji J
PLoS One; 2018; 13(1):e0189294. PubMed ID: 29370182
[TBL] [Abstract][Full Text] [Related]
59. Primary radio(chemo)therapy for esophageal cancer in elderly patients: are efficiency and toxicity comparable with younger patients?
Münch S; Heinrich C; Habermehl D; Oechsner M; Combs SE; Duma MN
Eur J Med Res; 2017 Jul; 22(1):24. PubMed ID: 28683820
[TBL] [Abstract][Full Text] [Related]
60. Predictive Factors of Recurrence in Patients with Pathological Complete Response After Esophagectomy Following Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Study.
Luc G; Gronnier C; Lebreton G; Brigand C; Mabrut JY; Bail JP; Meunier B; Collet D; Mariette C
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1357-64. PubMed ID: 26014152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
